Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00289367 · ClinicalTrials.gov registry record · Phase 1
Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery
A Phase 1 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 280
- Enrollment target
NCT00289367 is a Phase 1 study that has completed, run by Northwell Health. The registered enrollment target is 280 participants.
The verdict
NCT00289367, a Phase 1 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 280 participants
- Enrollment target
Study Summary
The purpose of this project is to see whether treatment with a thyroid hormone, called triiodothyronine or T3, following open heart surgery reduces the risk of developing atrial fibrillation.
Interventions
- DRUG triiodothyronine
- DRUG Triiodothyronine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00289367
The ClinicalTrials.gov registry entry for NCT00289367 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which triiodothyronine is the first listed.
NCT00289367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00289367 about?
NCT00289367 is a clinical study titled "Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery". The purpose of this project is to see whether treatment with a thyroid hormone, called triiodothyronine or T3, following open heart surgery reduces the risk of developing atrial fibrillation.
What is the current status of trial NCT00289367?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 280 participants. The study started on 2006-02. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00289367?
The interventions under investigation include: triiodothyronine (DRUG), Triiodothyronine (DRUG).
Who is sponsoring clinical trial NCT00289367?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.